InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
3
Disclosed sells
0
T+90 hit rate
44%
T+90 mean return
-0.2%
Across 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Sigal Charles Elliott, Director. Director active across 3 companies, notably Vir Biotechnology, Inc.. In total, 11 filings have been logged. Breakdown: 3 buys · 0 sell. Total volume traded: €172k. Activity tracked since 21 May 2021. The latest transaction was filed on 20 May 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations11 total
671 shares0Common StockSEC:0001178670-26-000042:0
775 shares0Common StockSEC:0001735276-25-000060:0
8,000 shares0Common StockSEC:0001628280-24-026221:0
45,453 sharesCommon StockSEC:0001209191-23-048762:0
6,027 shares0Common StockSEC:0001209191-23-031840:0
2,500 shares@ US$22.726231.1% of flowCommon StockSEC:0001209191-23-014673:0
Ideal exit: 26 Nov 2023 (T+270)
2,500 shares@ US$24.958234.1% of flowCommon StockSEC:0001209191-23-002507:0
Ideal exit: 2 Oct 2023 (T+270)
2,500 shares@ US$25.59734.7% of flowCommon StockSEC:0001209191-23-001932:0
Ideal exit: 30 Sept 2023 (T+270)
6,405 shares0Common StockSEC:0001209191-22-031959:0
3,374 shares0Common StockSEC:0001209191-21-035717:0
3,374 shares0Common StockSEC:0001209191-21-035717
11 of 11 declarations
About Sigal Charles Elliott
Charles Elliott Sigal is a Board Member at Vir Biotechnology, Inc. As a board member, he participates in the governance and strategic decision-making of the company. His experience in the biopharmaceutical sector allows him to provide valuable insights for the company's development. Charles Sigal plays an active role in evaluating performance and growth opportunities.
